Tuberculosis and diabetes: bidirectional screening and management challenges in South Indian population
DOI:
https://doi.org/10.18203/2320-6012.ijrms20253145Keywords:
Tuberculosis, Lung disease, Extra pulmonary tuberculosis, Comorbidity, Screening diabetesAbstract
Background: The World Health Organization (WHO) and the International Union Against Tuberculosis and Lung Disease have advocated for bidirectional screening testing TB patients for diabetes and vice versa—as a strategic approach to early detection and integrated management. Aim of the study is to evaluate the effectiveness, feasibility, and challenges of bidirectional screening for tuberculosis (TB) and diabetes mellitus (DM), and to identify barriers and opportunities for integrated management of coexisting TB and DM in high-burden settings.
Methods: This was a prospective, observational, cross-sectional study conducted to evaluate the implementation and challenges of bidirectional screening for tuberculosis (TB) and diabetes mellitus (DM) in a high-burden tertiary care setting. The study was carried out over a period of three years from February 2022 to January 2025.
Results: High undiagnosed DM in TB patients (27.2%) and TB in DM patients (15.3%), underscoring bidirectional screening gaps. TB and DM patients had poorer treatment outcomes (73.5% success vs. 85.7%, *p=0.03*). Systemic barriers: kit shortages (52%) and protocol inconsistencies (44%) dominated challenges. Age >45 and pulmonary TB doubled DM risk (OR>1.8, p<0.02).
Conclusions: Our study demonstrated a substantial prevalence of undiagnosed diabetes among TB patients and active TB among diabetic patients, both of which adversely affected treatment outcomes. Bidirectional screening is crucial for early detection, timely intervention, and improved clinical outcomes.
Metrics
References
Shivakumar SVBY, Chandrasekaran P, Kumar AMV, Paradkar M, Dhanasekaran K, Suryavarshini N, et al. Diabetes and pre-diabetes among household contacts of tuberculosis patients in India: is it time to screen them all? Int J Tuberc Lung Dis. 2018;22(6):686-94. DOI: https://doi.org/10.5588/ijtld.17.0598
Harries AD, Satyanarayana S, Kumar AM, Nagaraja SB, Isaakidis P, Malhotra S, et al. Epidemiology and interaction of diabetes mellitus and tuberculosis and challenges for care: a review. Public Health Action. 2013;3(Suppl 1):S3-9. DOI: https://doi.org/10.5588/pha.13.0024
Baker MA, Harries AD, Jeon CY. Hart JE, Kapur A, Lönnroth K. The impact of diabetes on tuberculosis treatment outcomes: A systematic review. BMC Med. 2011;9:81. DOI: https://doi.org/10.1186/1741-7015-9-81
Sen T, Joshi SR, Udwadia ZF. Tuberculosis and diabetes mellitus: merging epidemics. J Assoc Physicians India. 2009;57:399-404.
World Health Organization & The Union. Collaborative framework for care and control of tuberculosis and diabetes. Geneva: WHO; 2011
Balakrishnan S, Vijayan S, Nair S, Subramoniapillai J, Mrithyunjayan S, Wilson N, et al. High diabetes prevalence among tuberculosis cases in Kerala, India. PLoS One. 2012;7(10):e46502. DOI: https://doi.org/10.1371/journal.pone.0046502
American Diabetes Association. Standards of medical care in diabetes—2023. Diabetes Care. 2023;46(Supplement_1):S1–S291.
Hayashi S, Chandramohan D. Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis. Trop Med Int Health. 2018;23(10):1058-70. DOI: https://doi.org/10.1111/tmi.13133
India Tuberculosis-Diabetes Study Group. Screening of patients with tuberculosis for diabetes mellitus in India. Trop Med Int Health. 2013;18(5):636-45. DOI: https://doi.org/10.1111/tmi.12084
Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7):e152. DOI: https://doi.org/10.1371/journal.pmed.0050152
Restrepo BI, Fisher-Hoch SP, Crespo JG, Whitney E, Perez A, Smith B, et al. Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect. 2007;135(3):483-91. DOI: https://doi.org/10.1017/S0950268806006935
Fisher-Hoch SP, Whitney E, McCormick JB, Crespo G, Smith B, Rahbar MH, et al. Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect Dis. 2008;40(11-12):888-93. DOI: https://doi.org/10.1080/00365540802342372
Vaishya R, Misra A, Vaish A, Singh SK. Diabetes and tuberculosis syndemic in India: A narrative review of facts, gaps in care and challenges. J Diabetes. 2024;16(5):e13427. DOI: https://doi.org/10.1111/1753-0407.13427
Riza AL, Pearson F, Ugarte-Gil C, Alisjahbana B, van de Vijver S, Panduru NM, et al. Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol. 2014;2(9):740-53. DOI: https://doi.org/10.1016/S2213-8587(14)70110-X
Zhou TJ, Lakshminarayanan S, Sarkar S, Knudsen S, Horsburgh CR, Muthaiah M, et al. Predictors of Loss to Follow-Up among Men with Tuberculosis in Puducherry and Tamil Nadu, India. Am J Trop Med Hyg. 2020;103(3):1050-6. DOI: https://doi.org/10.4269/ajtmh.19-0415
Lönnroth K, Roglic G, Harries AD. Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice. Lancet Diabetes Endocrinol. 2014;2(9):730-9. DOI: https://doi.org/10.1016/S2213-8587(14)70109-3
Downloads
Published
How to Cite
Issue
Section
